» Articles » PMID: 32397771

Design and Optimization of Candesartan Loaded Self-nanoemulsifying Drug Delivery System for Improving Its Dissolution Rate and Pharmacodynamic Potential

Overview
Journal Drug Deliv
Specialty Pharmacology
Date 2020 May 14
PMID 32397771
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

During the last decades, much attention has been focused on SNEDDS approach to resolve concerns of BCS II class drugs with accentuation on upgrading the solubility and bioavailability. The present hypothesis confirms the theory that SNEDDS can reduce the impact of food on Candesartan solubilization, thereby offering the potential for improved oral delivery without co-administration with meals. The present studies describe quality-by-design-based development and characterization of Candesartan loaded SNEDDS for improving its pharmacodynamic potential. D-optimal mixture design was used for systematic optimization of SNEDDS, which showed globule size of 13.91 nm, more rapid drug release rate of >90% in 30 min and 16 s for self-emulsification. The optimized formulations were extensively evaluated, where an drug release study indicated up to 1.99- and 1.10-fold enhancement in dissolution rate from SNEDDS over pure drug and marketed tablet. pharmacodynamic investigation also showed superior antihypertensive potential of SNEDDS in normalizing serum lipid levels as compared to pure drug and marketed tablet that was executed on male Wistar rats. Overall, this paper reports successful systematic development of candesartan-loaded SNEDDS with distinctly improved biopharmaceutical performance. This research work interpreted a major role of SNEDDS for enhancing the rate of dissolution and bioavailability of poorly water soluble drugs.

Citing Articles

Solid Self-Microemulsifying Drug Delivery System for Improved Oral Bioavailability of Relugolix: Preparation and Evaluation.

Li Z, Deng G, Fang C, Zhao Y, Yuan J, Chen L Int J Nanomedicine. 2025; 20:1065-1082.

PMID: 39886543 PMC: 11780666. DOI: 10.2147/IJN.S497099.


Valsartan Loaded Solid Self-Nanoemulsifying Delivery System to Enhance Oral Absorption and Bioavailability.

Chen L, Zhang X, Xie J, Xiao T, Zhong H, He H AAPS PharmSciTech. 2025; 26(1):45.

PMID: 39849239 DOI: 10.1208/s12249-024-03032-0.


Olive oil and castor oil-based self-nanoemulsifying drug delivery system of flurbiprofen can relieve peripheral pain and inflammation through reduction of oxidative stress and inflammatory biomarkers: a comprehensive formulation and pharmacological....

Basar M, Khan M, Akhtar M, Anwar F, Saleem A, Madni A Inflammopharmacology. 2025; 33(1):353-379.

PMID: 39776028 DOI: 10.1007/s10787-024-01632-7.


Preparation, process optimisation, stability and bacteriostatic assessment of composite nanoemulsion containing corosolic acid.

Li H, Tan X, Qin L, Gatasheh M, Zhang L, Lin W Heliyon. 2024; 10(19):e38283.

PMID: 39386795 PMC: 11462487. DOI: 10.1016/j.heliyon.2024.e38283.


In Vitro and in vivo characterization of nasal pH-Responsive in-situ hydrogel of Candesartan-loaded invasomes as a potential stroke treatment.

El-Housiny S, Fouad A, El-Bakry R, Zaki R, Afzal O, Abo El-Ela F Drug Deliv Transl Res. 2024; .

PMID: 39259459 DOI: 10.1007/s13346-024-01700-z.


References
1.
Mohsin K . Design of lipid-based formulations for oral administration of poorly water-soluble drug fenofibrate: effects of digestion. AAPS PharmSciTech. 2012; 13(2):637-46. PMC: 3364387. DOI: 10.1208/s12249-012-9787-2. View

2.
Liu Y, Sun C, Hao Y, Jiang T, Zheng L, Wang S . Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles. J Pharm Pharm Sci. 2011; 13(4):589-606. DOI: 10.18433/j3530j. View

3.
Nornoo A, Zheng H, Lopes L, Johnson-Restrepo B, Kannan K, Reed R . Oral microemulsions of paclitaxel: in situ and pharmacokinetic studies. Eur J Pharm Biopharm. 2008; 71(2):310-7. DOI: 10.1016/j.ejpb.2008.08.015. View

4.
Kalantari A, Kosa D, Nemes D, Ujhelyi Z, Feher P, Vecsernyes M . Self-Nanoemulsifying Drug Delivery Systems Containing Plantago lanceolata-An Assessment of Their Antioxidant and Antiinflammatory Effects. Molecules. 2017; 22(10). PMC: 6151772. DOI: 10.3390/molecules22101773. View

5.
Gleiter C, Jagle C, Gresser U, Morike K . Candesartan. Cardiovasc Drug Rev. 2004; 22(4):263-84. DOI: 10.1111/j.1527-3466.2004.tb00146.x. View